Category public

Nigerian equities market rebounds with N1.58 trillion gain

Market bounces back after previous session’s losses

The Nigerian equities market staged a strong recovery on Thursday, July 23, 2026, adding N1.58 trillion to its overall market capitalization. The rebound reversed the losses recorded in the prior trading session, driven by renewed buying interest in large-cap stocks that outweighed ongoing profit-taking activities.

What drove the recovery

According to a report from Nairametrics, the gain was fueled by a shift in investor sentiment toward heavyweight stocks. Traders moved back into blue-chip equities, providing enough upward momentum to offset the selling pressure from profit-taking that had weighed on the market in the preceding days.

Market context and implications

The N1.58 trillion increase represents a significant single-day swing in valuation, underscoring the volatility that has characterized the Nigerian equities market in recent sessions. For investors, the rebound highlights the continued influence of large-cap stocks on the broader market’s direction. When buying interest concentrates on these major names, it can quickly reverse broader market trends, as seen on Thursday.

Profit-taking had been a dominant theme in the previous session, pulling the market lower. The quick reversal suggests that many investors still see value in the large-cap space, even as some choose to lock in gains. This tug-of-war between buying and selling is typical in markets that have experienced a sustained run-up, and it often signals a period of consolidation.

What this means for investors

For retail and institutional investors alike, the rebound serves as a reminder of the importance of monitoring large-cap activity. These stocks often act as bellwethers for the entire market. When they attract strong buying interest, the ripple effect can lift the entire index and market capitalization, as happened on July 23.

However, the persistence of profit-taking suggests that not all market participants are convinced the rally will continue uninterrupted. Investors should watch for sustained buying volume in the coming sessions to confirm whether the rebound marks the start of a new upward leg or merely a temporary pause in a broader pullback.

Looking ahead

The coming trading days will be critical in determining whether the Nigerian equities market can build on Thursday’s gains. If large-cap stocks continue to attract buyers, the market could recover more of its recent losses. Conversely, if profit-taking resumes with greater intensity, the N1.58 trillion gain may prove short-lived. The balance between these forces will shape the market’s near-term trajectory.

Source: Nairametrics

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.